Affective and psychotic disorders in multiple sclerosis

被引:4
作者
Pozuelo-Moyano, Beatriz [1 ]
Benito-Leon, Julian [2 ,3 ,4 ]
机构
[1] Hop Univ Geneve, Serv Med Interna Rehabil & Geriatria, Geneva, Switzerland
[2] Hosp Univ 12 Octubre, Serv Neurol, Madrid, Spain
[3] Univ Complutense Madrid, Dept Med, Fac Med, Madrid, Spain
[4] CIBERNED, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
关键词
Affective disorders; Multiple sclerosis; Psychotic disorders; Review; QUALITY-OF-LIFE; CLINICALLY ISOLATED SYNDROME; PITUITARY-ADRENAL AXIS; DEPRESSIVE SYMPTOMS; MAJOR DEPRESSION; MICROGLIAL ACTIVATION; SCHIZOPHRENIA; BRAIN; IMPAIRMENT; MECHANISMS;
D O I
10.33588/rn.6111.2015206
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Multiple sclerosis (MS) is the second most important cause of disability of a neurological origin in young adults. Both the physical and the psychiatric (affective and psychotic disorders) clinical signs and symptoms have a negative impact on the patients' health-related quality of life. Aim. To shed light on the prevalence and pathogenesis of the affective and psychotic symptoms present in MS. Development. This review includes an update of the most significant studies published in the literature that have analysed the prevalence and pathogenesis of affective and psychotic signs and symptoms in patients with MS. The evidence available to date was reviewed in order to explore the association between the affective and psychotic symptoms of MS. Conclusions. Depression is the most frequent psychiatric disorder in MS. Further research is needed to clarify the underlying mechanisms that can trigger affective and psychotic symptoms in MS. Controlling those symptoms in patients with MS could improve their health-related quality of life.
引用
收藏
页码:503 / 508
页数:6
相关论文
共 59 条
[1]  
Aggarwal A, 2011, Int MS J, V17, P54
[2]   Anxiety and depressive symptoms in clinically isolated syndrome and multiple sclerosis [J].
Anhoque, Carolina Fiorin ;
Aires Domingues, Simone Cristina ;
Carvalho, Thiago ;
Teixeira, Antonio Lucio ;
Domingues, Renan Barros .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2011, 69 (06) :882-886
[3]   Depression and anxiety amongst multiple sclerosis patients [J].
Beiske, A. G. ;
Svensson, E. ;
Sandanger, I. ;
Czujko, B. ;
Pedersen, E. D. ;
Aarseth, J. H. ;
Myhr, K. M. .
EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (03) :239-245
[4]   A review about the impact of multiple sclerosis on health-related quality of life [J].
Benito-León, J ;
Morales, JM ;
Rivera-Navarro, J ;
Mitchell, AJ .
DISABILITY AND REHABILITATION, 2003, 25 (23) :1291-1303
[5]   Multiple sclerosis in Mostoles, central Spain [J].
Benito-Leon, J ;
Martin, E ;
Vela, L ;
Villar, ME ;
Felgueroso, B ;
Marrero, C ;
Guerrero, A ;
Ruiz-Galiana, J .
ACTA NEUROLOGICA SCANDINAVICA, 1998, 98 (04) :238-242
[6]   Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients [J].
Benito-León, J ;
Morales, JM ;
Rivera-Navarro, J .
EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (05) :497-502
[7]   Are the Prevalence and Incidence of Multiple Sclerosis Changing? [J].
Benito-Leon, Julian .
NEUROEPIDEMIOLOGY, 2011, 36 (03) :148-149
[8]   The CAREQOL-MS was a useful instrument to measure caregiver quality of life in multiple sclerosis [J].
Benito-Leon, Julian ;
Rivera-Navarro, Jesus ;
Luis Guerrero, Angel ;
de las Heras, Virginia ;
Balseiro, Jose ;
Rodriguez, Elena ;
Bello, Mireia ;
Martinez-Martin, Pablo .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (06) :675-686
[9]   Is the epidemiology of multiple sclerosis changing? [J].
Benito-Leon, Julian ;
Bermejo-Pareja, Felix .
REVISTA DE NEUROLOGIA, 2010, 51 (07) :385-386
[10]   The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-γ [J].
Bian, Qian ;
Kato, Takahiro ;
Monji, Akira ;
Hashioka, Sadayuki ;
Mizoguchi, Yoshito ;
Horikawa, Hideki ;
Kanba, Shigenobu .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (01) :42-48